Skip to main content
SpringerLink
Log in

Pharmacokinetics of propranolol

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The pharmacokinetics of propranolol after the administration of 40, 80, and 120 mg p.o. and 10 mg i.v. was studied in nine healthy male volunteers. Propranolol was analyzed after extraction and derivatization by gas-liquid chromatography. A multiexponential curve-stripping program was used for the pharmacokinetic analysis. The volume of distribution was about 6 liters · kg −1,bioavailability around 25%, with a mean terminal half-life of 6hr. There was no evidence of either dose dependent disposition kinetics or an oral threshold dose. A slight increase in urine volume was observed after propranolol administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. W. Paterson, M. E. Conolly, C. T. Dollery, A. Hayes, and R. G. Cooper. The pharmacodynamics and metabolism of propranolol in man.Pharmacol. Clin. 2:127–133 (1970).

    Article  CAS  Google Scholar 

  2. D. G. Shand, E. M. Nuckolls, and J. A. Oates. Plasma propranolol levels in adult.Clin. Pharmacol. Ther. 11:112–120 (1970).

    CAS  PubMed  Google Scholar 

  3. C. F. George, T. Fenyvesi, M. E. Conolly, and C. T. Dollery. Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.Eur. J. Clin. Pharmacol. 4:74–76 (1972).

    Article  CAS  PubMed  Google Scholar 

  4. D. G. Shand and R. E. Rangno. The disposition of propranolol. I. Elimination during oral absorption in man.Pharmacology. 7:159–168 (1972).

    Article  CAS  PubMed  Google Scholar 

  5. G. H. Evans and D. G. Shand. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.Clin. Pharmacol. Ther. 14:487–493 (1973).

    CAS  PubMed  Google Scholar 

  6. G. H. Evans and D. G. Shand. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.Clin. Pharmacol. Ther. 14:494–500 (1973).

    CAS  PubMed  Google Scholar 

  7. G. H. Evans, A. S. Nies, and D. G. Shand. The disposition of propranolol. III. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.J. Pharmacol. Exp. Ther. 186:114–122 (1973).

    CAS  PubMed  Google Scholar 

  8. C. A. Chidsey, P. Morselli, G. Bianchetti, A. Morganti, G. Leonetti, and A. Zanchetti. Studies of the absorption and removal of propranolol in hypertensive patients during therapy.Circulation 52:313–318 (1975).

    Article  CAS  PubMed  Google Scholar 

  9. R. Gomeni, G. Bianchetti, R. Sega, and P. L. Morselli. Pharmacokinetics of propranolol in normal healthy volunteers.J. Pharmacokin. Biopharm. 5:183–192 (1977).

    Article  CAS  Google Scholar 

  10. A. J. J. Wood, R. E. Vestal, G. R. Wilkinson, and D. G. Shand. Comparison of the bioavailability of propranolol during single and chronic oral dosing.Clin. Pharmacol. Ther. 23:137–370 (1978).

    Google Scholar 

  11. Y. A. Weiss, M. E. Safar, C. Chevillard, A. Frydman, A. Simon, P. Lemaire, and J. M. Alexandre. Comparison of the pharmacokinetics of intravenous DL-propranolol in borderline and permanent hypertension.Eur. J. Clin. Pharmacol. 10:387–393 (1976).

    Article  CAS  PubMed  Google Scholar 

  12. A. S. Nies and D. G. Shand. Clinical pharmacology of propranolol.Circulation 52:6–15 (1975).

    Article  CAS  PubMed  Google Scholar 

  13. R. Davies, A. Morganti, P. Morselli, T. Pickering, G. Bianchetti, J. Romankiewicz, and J. Laragh. Beta-blockade and blood-levels after low-dose oral propranolol: the hepatic “first-pass” threshold revisited.Lancet 1:407–410 (1978).

    Article  CAS  PubMed  Google Scholar 

  14. L. Borgström, C. G. Johansson, H. Larsson, and R. Lenander. Pharmacokinetics of bendroflumethiazide after low oral doses.J. Pharmacokin. Biopharm. 9:431–441 (1981), this issue.

    Article  Google Scholar 

  15. R. H. Gotham and D. Shand. Spuriously low plasma propranolol concentrations resulting from blood collection methods.Clin. Pharmacol. Ther. 18:535–538 (1975).

    Google Scholar 

  16. E. Di Salle, K. M. Baker, S. R. Bareggi, W. D. Watkins, C. A. Chidsey, A. Frigerio, and P. M. Marselli. A sensitive gas chromatographie method for the determination of propanolol in human plasma.J. Chromatogr. 84:347–353 (1973).

    Article  PubMed  Google Scholar 

  17. T. Walle. GLC determination of propranolol, other β-blocking drugs, and metabolites in biological fluids and tissues.J. Pharm. Sci. 63:12:1885–1891 (1974).

    Article  CAS  PubMed  Google Scholar 

  18. C. M. Metzler. A users manual for NONLIN. The Upjohn Company Technical Report 7292/69/7292/005, Kalamazoo, Mich., 1969.

  19. A. J. Sedman and J. G. Wagner. AUTOAN, a decision-making pharmacokinetic computer program. Publication Distribution Service, Ann Arbor, Mich., 1974.

    Google Scholar 

  20. A. Hayes and R. G. Cooper. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.J. Pharmacol. Exp. Ther. 176:302–311 (1971).

    CAS  PubMed  Google Scholar 

  21. R. C. Tarazi, E. D. Frohlich, and H. P. Duston. Plasma volume changes with long-term beta-adrenergic blockade.Am. Heart J. 82:770–776 (1971).

    Article  CAS  PubMed  Google Scholar 

  22. J. L. Imbs, M. O. Spach, M. Schmidt, and J. Schwartz. Effet du propranolol sur la concentration des urines.Thérapie. 32:329–335 (1977).

    CAS  PubMed  Google Scholar 

  23. A. Westerlund and L. Hansson. Once daily treatment of hypertension.Br. Med. J. 2:877 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Research & Development, Biochemistry Laboratory AB Ferrosan, P.O.Box 839, S-201 80, Malmö, Sweden

    Lars Borgström, Carl-Gustav Johansson, Hans Larsson & Rune Lenander

Authors
  1. Lars Borgström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carl-Gustav Johansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Larsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rune Lenander
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borgström, L., Johansson, CG., Larsson, H. et al. Pharmacokinetics of propranolol. Journal of Pharmacokinetics and Biopharmaceutics 9, 419–429 (1981). https://doi.org/10.1007/BF01060886

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01060886

Key words

Search

Navigation